Village Dental Group Of Central Square Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 537 S Main St, Central Square, NY 13036 Phone: 315-676-3001 Fax: 315-676-3785 |
Central Square Dental Associates Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 3033 East Ave, Central Square, NY 13036 Phone: 315-668-5600 |
Central Square Smiles Dentistry Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 653 S Main St, Central Square, NY 13036 Phone: 315-668-6261 |
Palma And Nardozza Dental Services Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 537 S Main St, Central Square, NY 13036 Phone: 315-676-3001 |
News Archive
MicroDose Therapeutx Inc. (formerly MicroDose Technologies) today announced that it has initiated a Phase I study at the University of Pittsburgh Medical Center with atropine sulfate delivered from the MicroDose proprietary dry powder inhaler (DPI). The study is a further step in the development program for an atropine inhaler to treat nerve agent poisoning in military and civil defense applications.
Scientists at the University of Chicago found that rats which were prone to developing breast tumours were 3.3 times more likely to develop cancer if they were kept in isolation and suffered related stress.
Hospice Foundation of America (HFA) is pleased to announce the launch of its newest educational offering, the Hospice Information Center for families, friends and professionals. This centralized resource is part of "HFA CARES: Hospice Foundation of America's Conversations, Advice, Resources and Education Series," funded by the Centers for Medicare & Medicaid Services (CMS), and can be found at www.hospicefoundation.org/infocenter.
Many patients diagnosed with prostate cancer have indolent, slow-growing forms of the disease that are not life-threatening. However, more than 30,000 American men will die from aggressive prostate cancer this year alone. This sharp contrast between low-risk and aggressive disease presents a challenge for many researchers and physicians as they diagnose patients and also determine the prognosis of the men with the most aggressive forms of prostate cancer.
› Verified 8 days ago